author-photo

J. Fernando Mandujano

2

Papers

8

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies.

2021 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies

2019 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (8)